Black Diamond Therapeutics Total Liabilities

Black Diamond Therapeutics (BDTX) currently reports a total liabilities of $29M as of June 2026. That compares with $34M in the prior-year period — down 14.3% year over year. Use the charts on this page to explore Black Diamond Therapeutics's total liabilities history and peer comparisons.

Black Diamond Therapeutics's total liabilities decreased from $34M to $29M — a 14.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Black Diamond Therapeutics reported $29M in total liabilities as of June 2026. That compares with $34M in the prior-year period — down 14.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $29M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Black Diamond Therapeutics, and consider following BDTX for alerts when major investors trade the stock.

Black Diamond Therapeutics is classified in the Healthcare sector. On total liabilities, it currently shows $29M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BDTX with unrelated industries.